Morgan Chittum
Senior Finance Reporter
Fortune
Roundtable Program
As the life sciences industry heads into the 2027 J.P. Morgan Healthcare Conference, signs of renewed momentum are colliding with a media environment that is noisier, faster and increasingly shaped by AI.
Has the biotech market truly bounced back—and will the momentum hold? Which scientific, business and policy stories will command reporters’ attention in San Francisco? And at a time when journalists are inundated with pitches, press releases and AI-generated content, what does it take for a company, story or source to stand out?
Ticket to Biotech’s annual pre-JPM journalist panel brings together leading healthcare and business journalists—and a fresh perspective from today’s evolving independent media landscape—to look back at the stories that defined 2026 and ahead to the themes likely to shape JPM and the year to come.